ACCREDITATION

ADALIMUMAB

ADHERENCE

ADMINISTRATION-INTRAPARTUM

AGALSIDASE

AGNUS CASTUS

ALEFACEPT

ALEMTUZUMAB

ALITRETINOIN

ALMOTRIPTAN

ALOSETRON

ALPHA1 ANTITRYPSIN (replaces ALPHA-1 ANTITRYPSIN)

AMFEBUTAMONE (replaces BUPROPION)

ANGIOGENESIS INHIBITORS

ANTIPHOSPHOLIPID SYNDROME

ANTIRETROVIRALS

ANTIRHEUMATIC AGENTS

AORTOCORONARY BYPASS (delete - use CORONARY ARTERY BYPASS)

ARBOVIRUSES

ARENAVIRUSES

ARISTOLOCHIA

AUTOMATION

AZIMILIDE

BACTERAEMIA

BATCH NUMBERS

BENZPHETAMINE

BILE ACID SEQUESTRANTS

BIOFLAVONOIDS

BIPOLAR DISORDER

BLAISE (delete)

BRONCHODILATORS AND ANTI-ASTHMATICS (replaces BRONCHODILATORS)

BRONCHODILATORS-ANTIMUSCARINIC

BULIMIA

BUPROPION (delete - use AMFEBUTAMONE)

CARDIOVERSION

CASPOFUNGIN

CEFDITOREN

CENTRE FOR PHARMACY POSTGRADUATE EDUCATION

CETRORELIX

CHECKING-PROFESSIONAL

CHIROPRACTIC

CHOLESTEROL ABSORPTION INHIBITORS

CHONDROITIN

CICLESONIDE

CILOMILAST

CLINICAL GOVERNANCE

CLINICAL GUIDELINES

COLESEVELAM

COMMISSION FOR HEALTH IMPROVEMENT

COMMUNICATION-ELECTRONIC

COMPETITION ACT

COMPLAINTS

CONTINUING PROFESSIONAL DEVELOPMENT

CONTINUOUS PROFESSIONAL DEVELOPMENT (delete -use CONTINUING PROFESSIONAL DEVELOPMENT)

CORONARY ARTERY BYPASS

CYTOPHOTOMETRY

DARBEPOETIN

DEFIBRILLATORS

DEHYDROEPIANDROSTERONE (delete - use PRASTERONE)

DEMENTIA-PRESENILE (delete)

DEMENTIA-SENILE (delete)

DEMENTIA-VASCULAR

DEMOGRAPHICS

DEOXYFLUOROTHYMIDINE (delete)

DESLORATADINE

DIDEOXYNUCLEOSIDES (delete)

DIETARY SUPPLEMENTS

DIPHTHERIA PERTUSSIS TETANUS VACCINE

DISCIPLINE

DISCUSSION GROUPS-INTERNET

DISPENSING-EXTEMPORANEOUS

DOCOSANOL

DROTRECOGIN

DRUG INFORMATION (delete - use MEDICINES INFORMATION)

DRUG INFORMATION CENTRES (delete - use MEDICINES INFORMATION CENTRES)

DRUG INFORMATION SERVICES (delete - use MEDICINES INFORMATION SERVICES)

DRUGS-UNLICENSED

DRY EYE SYNDROMES

DUTASTERIDE

EATING DISORDERS

EBOLA VIRUS

ECADOTRIL

EDUCATION-PHARMACY

EDUCATION-POSTGRADUATE

ELECTRIC COUNTERSHOCK (delete - replaced by CARDIOVERSION)

EMIVIRINE

EMPLOYMENT

ENDOTHELIN ANTAGONISTS

ENTERIC COATED PREPARATIONS

EPLERENONE

ERECTILE DYSFUNCTION AGENTS

ERRORS-MEDICATION

ESOMEPRAZOLE

ETORICOXIB

EZETIMIBE

FILOVIRUSES

FINANCIAL PLANNING

FISH OILS

FLYING

FOMIVIRSEN (replaces FOMIVERSIN)

FONDAPARINUX

FOOT AND MOUTH DISEASE

FOREIGN NATIONALS

FROVATRIPTAN

FUMARATE

GANIRELIX

GATIFLOXACIN

GEMIFLOXACIN

GEMTUZUMAB OZOGAMICIN

GENOME

GENOTYPE

GLUCOSAMINE

GLYCOPROTEIN IIB-IIIA ANTAGONISTS (replaces GLYCOPROTEIN IIA-IIIB ANTAGONISTS)

GRAFT-VERSUS-HOST DISEASE

GROUP PROTOCOL (deleted - replaced by PATIENT GROUP DIRECTIONS)

GROWTH HORMONE ANTAGONISTS

HEALTH TECHNOLOGY ASSESSMENT

HOMELESSNESS

HOMOCYSTEINE

HOSIERY-COMPRESSION

HOSPITALS-COMMUNITY

HUMAN RIGHTS

HYPERICUM

HYPERPHOSPHATAEMIA

HYPOMANIA

ICHTHAMMOL

ICODEXTRIN

IMATINAB

IMMUNISATION PROGRAMMES

IMMUNOTOXINS

INFORMATION TECHNOLOGY

INHALERS-BREATH ACTUATED

INHALERS-METERED DOSE

INSULIN GLARGINE

INSURANCE-HEALTH

INTUSSUSCEPTION

JUNIN VIRUS

KERATINOCYTE GROWTH FACTOR

LACTASE

LASSA VIRUS

LEARNING DISORDERS

LENERCEPT

LEUKOMALACIA-PERIVENTRICULAR

LEVOCETIRIZINE

LEWY BODIES

LHRH ANTAGONISTS

LINSEED

LOBELINE

LOPINAVIR

LOSOXAMIDE (delete)

LOTRAFIBAN

LUMEFANTRINE

MARBURG VIRUS

MEDICAL RECORDS-ELECTRONIC

MEDICINES INFORMATION

MEDICINES INFORMATION CENTRES

MEDICINES INFORMATION SERVICES

MEDICINES MANAGEMENT

MEDICINES-UNUSED

MELAGATRAN

MENINGOCOCCAL GROUP B VACCINE

MENINGOCOCCAL GROUP C VACCINE

MENTAL HEALTH

MENTAL HEALTH ACT

MEPOLIZUMAB

METALLOPORPHYRINS

METHYLNALTREXONE

MILTEFOSINE

MINOR AILMENTS

MITOCHONDRIA

MIVAZEROL

MOOD DISORDERS

MULTIPLE ORGAN FAILURE

MYELIN SHEATH

MYELOID METAPLASIA

MYELOPROLIFERATIVE DISORDERS

MYOCARDIAL REVASCULARISATION

NADIFLOXACIN

NATALIZUMAB

NATEGLINIDE

NATIONAL ELECTRONIC LIBRARY FOR HEALTH

NATIONAL PRESCRIBING CENTRE

NATIONAL SERVICE FRAMEWORKS

NESIRITIDE

NET INGREDIENT COST

NEUROPEPTIDES

NORELGESTROMIN

NURSES-PRACTICE

OBSERVATIONAL STUDIES

OMALIZUMAB

OMAPATRILAT

ORBOFIBAN

OROFIBAN (delete - use ORBOFIBAN)

OSELTAMIVIR

OSMOTIC DELIVERY SYSTEMS

OSTEOPATHY

OSTEOSARCOMA

P-GLYCOPROTEINS

PARECOXIB

PARVOVIRUSES

PATIENT EDUCATION

PATIENT GROUP DIRECTIONS

PATIENT REFERRAL

PEGVISOMANT

PERIARTERITIS NODOSA (delete - replaced by POLYARTERITIS NODOSA)

PERSONAL DEVELOPMENT

PERU BALSAM

PEXIGANAN

PHARMACISTS-PRIMARY CARE

PHENDIMETRAZINE

PIMECROLIMUS

POISONS ACT

POLYARTERITIS NODOSA

POLYETHYLENE GLYCOL

PRESCRIBING DATA

PRESCRIBING-ELECTRONIC

PRIMARY CARE TRUSTS

PROANTHOCYANIDINS

PYRUVATE

RACIAL FACTORS

RASBURICASE

REBOXETINE (replaces REMOXETINE)

RECEPTORS-LDL

RECEPTORS-LIPOPROTEIN

REPEAT DISPENSING

RESIDENTIAL HOMES

REVERSE TRANSCRIPTASE INHIBITORS-NONNUCLEOSIDE

REVERSE TRANSCRIPTASE INHIBITORS-NUCLEOSIDE

RHABDOMYOSARCOMA

RIBOZYMES

RIMEXOLONE

RISK MANAGEMENT

ROSEMARY

ROSUVASTATIN

SALMONELLA ENTERICA

SCOTTISH INTERCOLLEGIATE GUIDELINES NETWORK

SEPSIS

SEPSIS SYNDROME

SEROTONIN-1 RECEPTOR AGONISTS

SEVELAMER

SEXUAL HEALTH

SILIBININ

SIP FEEDING

SITAFLOXACIN

SITAMAQUINE

SMOKING CESSATION

SPORTS MEDICINE

ST JOHNS WORT (delete - use HYPERICUM)

STROMAL CELLS

STUDENTS

SUMMARY OF PRODUCT CHARACTERISTICS

SUPERVISION

TADALAFIL

TAFENOQUINE

TELEMEDICINE

TELITHROMYCIN

TEMOPORFIN

TENECTEPLASE

TENNIS ELBOW

TENOFOVIR

TEZOSENTAN

THROMBIN INHIBITORS

TIME MANAGEMENT

TIN-MESOPORPHYRIN

TIN-PROTOPORPHYRIN

TIOTROPIUM

TOMATOES

TRACHEOSTOMY

TRAVOPROST

TREPROSTINIL

TROPONIN

TROPONIN T

TUMOUR NECROSIS FACTOR ANTAGONISTS

TYROSINE KINASE INHIBITORS

URACIL

UROSTOMY

VACCINES-CONJUGATE

VAGINAL RINGS

VALERIAN

VALGANCICLOVIR

VARDENAFIL

VASOPEPTIDASE INHIBITORS

VERTEPORFIN

VIRAEMIA

VOGLIBOSE (replaces VOLGLIBOSE)

WASTING SYNDROME

XALIPRODEN

XIMELAGATRAN

ZALEPLON

ZOLEDRONATE